Immunoadsorption therapy reduces oxidative stress in patients with dilated cardiomyopathy

Kasai, Hajime; Kashima, Yuichiro; Izawa, Atsushi; Tomita, Takeshi; Miyashita, Yusuke; Koyama, Jun; Takahashi, Masafumi; Yoshio, Taku; Yazaki, Yoshikazu; Higuchi, Makoto; Ikeda, Uichi

doi:10.4236/wjcd.2012.24048

WJCD

2012

DOI: 10.4236/wjcd.2012.24048

|View full text |Cite

Immunoadsorption therapy reduces oxidative stress in patients with dilated cardiomyopathy

Hajime Kasai¹,

Yuichiro Kashima²,

Atsushi Izawa³

et al.

Abstract: ABSTRACT

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2013

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 28 publications

(34 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

Dilated cardiomyopathy update: infectious-immune theory revisited

Kawai

Matsumori

2013

Heart Fail Rev

View full text Add to dashboard Cite

Dilated cardiomyopathy is characterized by dilatation of the left or right ventricle, or both ventricles. The degree of myocardial dysfunction is not attributable to abnormal loading conditions. The infectious-immune theory has long been hypothesized to explain the pathogenesis of many etiologically unrecognized dilated cardiomyopathies. Inflammations followed by immune reactions, which may be excessive, in the myocardium, evoked by external triggers such as viral infections and/or autoimmune antibodies, continue insidiously, and lead to the process of cardiac remodeling with ventricular dilatation and systolic dysfunction. This ultimately results in dilated cardiomyopathy. Hepatitis C virus-associated heart diseases are good examples of cardiac lesions definitely induced by viral infections in humans that progress to a chronic stage through complicated immune mechanisms. Therapeutic strategies for myocarditis and dilated cardiomyopathy have been obtained through analyses of the acute, subacute, and chronic phases of experimental viral myocarditis in mice. The appropriate modulation of excessive immune reactions during myocarditis, rather than their complete elimination, appears to be a key option in the prevention and treatment of dilated cardiomyopathy. The clinical application of an NF-κB decoy and immune adsorption of IgG3 cardiac autoantibodies have been used as immunomodulating therapies and may provide novel approaches for the treatment of refractory patients with dilated cardiomyopathy. Conventional therapeutic agents for chronic heart failure such as β-blockers, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and aldosterone antagonists in particular should be re-evaluated on the basis of their anti-inflammatory properties in the treatment of dilated cardiomyopathy.

show abstract

Dilated cardiomyopathy update: infectious-immune theory revisited

Kawai

Matsumori

2013

Heart Fail Rev

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Immunoadsorption therapy reduces oxidative stress in patients with dilated cardiomyopathy

Abstract: ABSTRACT

Cited by 1 publication

References 28 publications

Dilated cardiomyopathy update: infectious-immune theory revisited

Dilated cardiomyopathy update: infectious-immune theory revisited

Contact Info

Product

Resources

About